Wednesday, 7 October 2026 Every NSE & BSE announcement, by company
ALFA Filings Every announcement, straight from the exchange

Concord Biotech Ltd

NSE: CONCORDBIO · BSE: 543960 · Pharmaceuticals & Biotechnology · 27 announcements

Share price
₹1,361.20
Market cap
₹14,240 Cr
Revenue (annual)
₹1,055 Cr
Net profit (annual)
₹260.9 Cr
P/E (TTM)
51.7×Sector 47.4×
Promoter holding
44.08%+0.00% QoQ
FII holding
7.53%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

13:28 IST BSE
Legal & Regulatory

Concord Biotech Legal & Regulatory

Concord Biotech filed a Certificate under SEBI Regulation 74(5) confirming dematerialisation of securities for Q June 2026. The filing is submitted to NSE and BSE.